4
Changes in Ownership
Entrada Therapeutics, Inc. Filed Acc 0001104659-22-084212
President and CEO sold 2,000 shares at $12.00 ($24,000)
From the SEC's structured data for this filing
Trades in this filing
Doshi Dipal · President and CEO
Table I: Non-derivative
1 line| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2022-07-27 | Sale : show line 1 in the form | −2,000 | $12.00 | $24,000 | 208,710 | D |
| Open-market sales · 2,000 sh · avg $12.00 · $24,000 | ||||||
Loading xslF345X03/tm2222095-2_4seq1.xml…